Thursday, January 28, 2021

India's Serum Institute seeks approval to conduct local trial for Novavax COVID-19 vaccine

In a UK trial, the same vaccine was found to be 89.3% effective, Serum
CEO Adar Poonawalla said.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indias-serum-institute-seeks-approval-to-conduct-local-trial-for-novavax-covid-19-vaccine/articleshow/80557135.cms

No comments:

Post a Comment